Newsroom » Experts
Download image: Bill Zule
zule rti.org
919-485-2797

William Zule

Senior Health Analyst

William Zule, DrPH, is a senior research health analyst who joined RTI in 1999. He has been involved in community-based HIV and hepatitis C virus epidemiology and prevention studies since 1989. Dr. Zule’s early work helped clarify the context of indirect sharing in HIV risk among injecting drug users (IDUs). Other work has called attention to the potential impact of syringe type on HIV and HCV transmission among IDUs and to HIV risks among methamphetamine users. He has also published a series of papers examining and assessing treatment readiness and entry among out-of-treatment drug users.

Education

DrPH, University of Texas School of Public-Houston; MPH, University of Texas School of Public Health-Houston; BA, University of Texas-San Antonio.

Publications

Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries — International Journal on Drug Policy
Zule, W.A., Cross, H.E., Stover, J., & Pretorius, C. (Jan 2013)
Low dead space syringes: Authors’ response — International Journal of Drug Policy
Zule, W.A., Cross, H.E., Stover, J., & Pretorius, C. (Jan 2013)
Current Interventions to Reduce Sexual Risk Behaviors and Crack Cocaine Use among HIV-Infected Individuals — Curr HIV/AIDS Rep
Wechsberg, W.M., Golin, C., El-Bassel, N., Hopkins, J., & Zule, W. (Dec 2012)
Results of a Pilot Study to Reduce Methamphetamine Use and Sexual Risk Behaviors Among Methamphetamine-Using Men Who Have Sex with Men (MSM) Not Currently in Treatment — Journal of Psychoactive Drugs
Zule, W.A., Poulton, W.E., Coomes, C.M., Mansergh, G., Charania, M., Wechsberg, W.M., & Jones, H.E. (Nov 2012)
Low dead-space syringes for preventing HIV among people who inject drugs: Promise and barriers — Curr Opin HIV AIDS
Zule, W.A. (Jul 2012)
View all publications by William Zule

Expertise

News